Long Vimta Labs LtdVimta labs has broken out after almost 2 years. Buy between 580-530 and EXIT if closes below 490
0%
0%
0%
0%
0%
0.37%
21.85INR
481.72MINR
3.151BINR
22.143M
About VIMTA LABS LTD.
Sector
CEO
Harita Vasireddi
Website
Headquarters
Hyderabad
Employees
1.368K
Founded
1984
ISIN
INE579C01029
Vimta Labs Ltd. engages in the provision of contract research and testing. It services include cGMP laboratory services; analytical food and water; preclinical research; clinical research; biopharma; environmental assessments; and clinical reference lab. The company was founded by Sivalinga Prasad Vasireddi in 1984 and is headquartered in Hyderabad, India.
BUY TODAY SELL TOMORROW for 5%DON’T HAVE TIME TO MANAGE YOUR TRADES?
- Take BTST trades at 3:25 pm every day
- Try to exit by taking 4-7% profit of each trade
- SL can also be maintained as closing below the low of the breakout candle
Now, why do I prefer BTST over swing trades? The primary reason is that I have observed that
VIMTALABS weekly BreakoutWeekly Breakout seen with LOW volume thus conviction in also low but one can give try by putting sl 485 for target of 550
vimta labs , heading towards 700,,accumulate near buying zonevimta labs , heading towards 700,,accumulate near buying zone
good structure 700 next target. accumulate near buying zonegood structure 700 next target. accumulate near buying zone.....the red line
VIMTALABS - SWING TRADEEntry - 415
Target - 475
SL - 397.5
Price retraced to EMA 10 & resuming Upmove
EMA 10 > EMA 21 > EMA 50 > EMA 150 > EMA 200
VIMTALAB LONG BTSTPlease look into the chart for a detailed understanding.
Consider these for short-term & swing trades with 2% profit.
For BTST trades consider booking
target for 1% - 2%
Please consider these ideas for educational purpose
Comment below if you are looking for any answers.
Topline Growth + Op Leverage ComboChart is self explanatory.
Vimta Labs is one of the well known food testing companies in India.
As per Management guidance,
1. Company is targeting 500 Cr Revenue for 2026; and
2. Margin Expansion upwards of 30%
At expected Revenue of 500 Cr and EBIT margins of 32% by 2026 - EBIT will be arou
VIMTA LABS TARGET UPDATE 13-4-2023Look fresh in range 340-360 for upside 400-430 med term with SL 320..!!!
Fundamentally strongBut at cmp 287 sl 275 cb
Target 1 305
Target 2 320
Target 3 330
Closing above 330 can go for 360+ 400
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
